Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02291939
Other study ID # FMT-IT-01
Secondary ID
Status Completed
Phase N/A
First received November 4, 2014
Last updated January 23, 2016
Start date January 2015
Est. completion date December 2015

Study information

Verified date January 2016
Source Domain Surgical, Inc.
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Observational

Clinical Trial Summary

The objective of the clinical trial is to determine the suitability of the FMwand Ferromagnetic Surgical System for parotidectomy and Head & Neck surgery.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with an indication for surgical intervention for a parotidectomy.

- ECOG status = 2.

- Life expectancy > 3 months.

- Age = 18 years old.

- Able to provide written informed consent and EU Data Protection Directive forms prior to admission to this study.

- Willingness to meet all of the expected requirements of this clinical protocol.

Exclusion Criteria:

- Age < 18 years old.

- Pregnant or breastfeeding.

- Vulnerable patient populations (homeless patients, patients with drug or alcohol dependence, etc.).

- Concomitant treatments that would affect clotting, post-operative healing, increased chances of infection.

- Previous radiation treatment

- Previous head or neck surgery

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Parotidectomy
Surgical Intervention with the FMwand Surgical System

Locations

Country Name City State
Italy San Camillo-Forlanini Hospital Roma

Sponsors (1)

Lead Sponsor Collaborator
Domain Surgical, Inc.

Country where clinical trial is conducted

Italy, 

References & Publications (3)

Bowers CA, Burns G, Salzman KL, McGill LD, Macdonald JD. Comparison of tissue effects in rabbit muscle of surgical dissection devices. Int J Surg. 2014;12(3):219-23. doi: 10.1016/j.ijsu.2013.12.014. Epub 2014 Jan 7. — View Citation

MacDonald JD, Bowers CA, Chin SS, Burns G. Comparison of the effects of surgical dissection devices on the rabbit liver. Surg Today. 2014 Jun;44(6):1116-22. doi: 10.1007/s00595-013-0712-4. Epub 2013 Sep 5. — View Citation

Tok, S et al. Comparison of a Novel Thermal Surgical Technology with Monopolar and Carbon Dioxide Laser in a Rat Glioma Model. Poster presentation.

Outcome

Type Measure Description Time frame Safety issue
Primary Intraoperative Serious Adverse Events as a Measure of Safety and Feasibility Safety and feasibility will be assessed by evaluating intra-operative serious adverse events, if any, and their relationship with the FMwand Ferromagnetic Surgical System. 1 day after surgery Yes
Secondary Post-operative drainiage Evaluation of Post-operative Drainage Beginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 days No
Secondary Swelling of surgical wound Evaluation of surgical wound appearance based on swelling Beginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 days No
Secondary Necrosis of surgical margins Serosity and necrosis of margins Beginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 days No
Secondary Length of hospital stay Number of days (post-operative) of hospital stay Beginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 days No